ClinicalTrials.govclosed
A Phase I Open-Label Dose Escalation Study of Intravenous INKmune In Patients With MDS or AML
ClinicalTrials.gov study NCT05933070. IPD Sharing: NO. Countries: 2. Publications: 25.
ShareScore
32/100
Overall dataset sharing score
Score breakdown
These five areas show where the dataset supports — or may limit — practical reuse.
- Stewardship
- 12
- Harmonization
- 12
- Access
- 0
- Reuse readiness
- 0
- Engagement
- 8